| Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868) |
|---|
| 04/09/2009 | WO2009043117A1 Novel aryl potassium channel blockers and uses thereof |
| 04/09/2009 | US20090093644 chemical synthesizing a N-(haloacetyl)-3,3-dinitro-azetidine compound; anticarciogenic, antiinflammatory, antihypoxic, antidiabetic agent; cardiovascular and autoimmune disease; rheumatoid arthritis, diabetic retinopathy |
| 04/09/2009 | US20090093627 Process for preparing intermediates of ezetimibe by microbial reduction |
| 04/09/2009 | CA2701579A1 Novel aryl potassium channel blockers and uses thereof |
| 04/08/2009 | CN101402598A Improved method for preparing 1-benzhydryl-3-aza ring butanol |
| 04/08/2009 | CN100475829C Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| 04/02/2009 | US20090088566 Usage of Poly-3-Hydroxybutyrates in Preparation of Beta-Lactam Compounds |
| 04/02/2009 | US20090087379 Radiofluorinated Compounds and their Preparation |
| 03/31/2009 | US7511159 Azetidine ring compounds and drugs comprising the same |
| 03/26/2009 | WO2009038759A2 1-(4-(benzylbenzamid0) -benzyl) azetidine-3-carboxylic acid derivatives and related compounds as slp receptor modulators for the treatment of immune disorders |
| 03/26/2009 | US20090082331 S1p receptor modulating compounds and use thereof |
| 03/26/2009 | CA2699417A1 S1p receptor modulating compounds and use thereof |
| 03/25/2009 | EP2039357A2 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 03/25/2009 | EP2038253A1 Biphenyl derivatives and their use in treating hepatitis c |
| 03/25/2009 | CN100471835C Anti-hypercholesterolemic compounds |
| 03/18/2009 | EP2035370A2 Tetralin and indane derivatives and uses thereof |
| 03/18/2009 | EP1513806B1 Sulphonic acid salts of mandelic acid derivatives |
| 03/18/2009 | CN100469777C Preparation process of aztreonam |
| 03/17/2009 | US7504522 e.g. 3-(2,4,4'-trichlorobenzhydryloxy)-N-(tert-butyl)azetidine-1-carboxamide; cannabinoid receptor antagonist; antidiabetic agent, antidepressant; eating disorders, obesity, nicotine addiction |
| 03/17/2009 | US7504432 Quaternary salt of (3-((2-(3,3-difluorocyclopentyl)-2-hydroxy-2-(4-methylphenyl)ethanoyl)oxy)-1,1-dimethylpyrrolidinium bromide; respiratory system disorders; chronic obstructive pulmonary diseases, bronchitis, asthma, emphysema, rhinitis; side effect reduction; inhalants; muscarinic receptor antagonists |
| 03/17/2009 | CA2339826C Process for the production of n-protected azetidine-2-carboxylic acids (azeohs) |
| 03/12/2009 | WO2009032326A1 New tetracycline derivatives as antiinfective agents |
| 03/12/2009 | US20090069576 Process for production of 1-(3-(2-(1-benzothiophen-5-yl)-ethoxy)propyl)azetidin-3-ol or salts thereof |
| 03/12/2009 | US20090069287 Substituted azacycloalkanes useful for treating cns conditions |
| 03/12/2009 | US20090069286 Deuterium-enriched aztreonam |
| 03/12/2009 | US20090069285 Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitor Activity |
| 03/12/2009 | US20090069284 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 03/11/2009 | CN101384532A Process for preparing optically active alcohols |
| 03/11/2009 | CN100467448C Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 03/10/2009 | US7501404 Substituted azetidinones |
| 03/05/2009 | US20090062527 Process for Preparing Optically Active Alcohols |
| 03/05/2009 | US20090062284 Thio-Substituted Biarylmethanesulfinyl Derivatives |
| 03/04/2009 | EP2029528A1 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor |
| 03/04/2009 | CN101379028A Chemical compounds |
| 03/03/2009 | US7498460 Isophthalic acid derivatives |
| 03/03/2009 | US7498431 Esterfying 3(S)-(4-hydroxyphenyl)-3-hydroxy-propionic acid with alcohol; activating the 3-hydroxy group with an alkylcarbonyl, alkylsulfonyl or arylsulfonyl chloride or anhydride; and cyclizing product with an aniline to form a 1-phenyl-4-(p-hydroxyphenyl)-2-azetidinone in presence of an alkali halide |
| 02/26/2009 | US20090054396 Substituted thiophenes and uses thereof |
| 02/25/2009 | CN101374804A Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease |
| 02/24/2009 | US7494988 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 02/24/2009 | US7494987 compounds with potent antitussive actions, high safety and less adverse actions; methyl 4-({1-[2-(4-cyanophenyl)ethyl]-3-hydroxyazetidin-3-ylmethyl}methylamino)benzoate |
| 02/19/2009 | WO2009021946A1 Novel compounds |
| 02/19/2009 | WO2009021945A1 New compounds |
| 02/19/2009 | WO2009021758A1 Arylsulfonamides having an analgesic effect |
| 02/19/2009 | US20090048441 Process for the Preparation of Ezetimibe |
| 02/19/2009 | US20090048226 Inhibitors of caspases |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/19/2009 | US20090047716 Reduction processes for the preparation of ezetimibe |
| 02/19/2009 | DE102007037373A1 New oxazolidinone derivatives are factor Xa inhibitors useful to treat e.g. acute coronary syndrome, myocardial infarction, angina pectoris, reocclusion, restenosis, stroke, artrial fibrillation, arrhythmia and blood clotting disorder |
| 02/19/2009 | CA2696556A1 New compounds |
| 02/19/2009 | CA2696302A1 New compounds |
| 02/18/2009 | EP2025675A1 Arylsulfonamides with analgetic activity |
| 02/18/2009 | EP2025668A1 Arylsulfonamides with analgetic activity |
| 02/18/2009 | CN101367831A Midbody for preparing carbpenem antibiotics and method of preparing the same |
| 02/12/2009 | US20090042851 Sulfonamide derivatives, preparation thereof and use thereof as antagonists of orexin 2 receptors |
| 02/12/2009 | US20090042819 Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of use |
| 02/12/2009 | CA2696247A1 Preparation of synthetic nucleosides via .pi.-allyl transition metal complex formation |
| 02/11/2009 | CN101365676A Azetidines as mek inhibitors for the treatment of proliferative diseases |
| 02/11/2009 | CN101362731A Heterocyclic compounds and methods of use |
| 02/11/2009 | CN101362713A Preparation method of (3S-trans)-3-amido-4-methyl-2-oxo-1-sulfoazetidine |
| 02/10/2009 | US7488829 Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 02/10/2009 | US7488818 Method for producing 1,4-diphenyl azetidinone derivatives |
| 02/05/2009 | WO2009016085A1 Spiro compounds useful as antagonists of the h1 receptor |
| 02/05/2009 | WO2009016048A1 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands |
| 02/05/2009 | WO2009015485A1 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 02/05/2009 | US20090036423 Immunosuppresant compounds and compositions |
| 02/05/2009 | US20090036420 Benzamide derivatives and their use for treating cns disorders |
| 02/05/2009 | CA2694724A1 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 02/05/2009 | CA2694362A1 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands |
| 02/05/2009 | CA2677049A1 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| 02/03/2009 | US7485732 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 02/03/2009 | US7485664 Inhibitors of TACE |
| 01/29/2009 | US20090029962 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as taar-ligands |
| 01/29/2009 | US20090029947 Sphingosine-1-phosphate receptor agonist and antagonist compounds |
| 01/28/2009 | CN100455566C Novel derivatives of aminocyclohexane |
| 01/27/2009 | US7482335 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 01/20/2009 | US7479504 Edg receptor agonists |
| 01/20/2009 | US7479496 Substituted spiro azabicyclics as modulators of chemokine receptor activity |
| 01/15/2009 | WO2009009550A1 Novel compounds as cannabinoid receptor ligands |
| 01/15/2009 | CA2690756A1 Novel compounds as cannabinoid receptor ligands |
| 01/14/2009 | EP2013165A1 Diphenylazetidinone derivates possessing cholesterol absor tion inhibitor activit. |
| 01/14/2009 | CN101346349A Process for the production of ezetimibe and intermediates used in this proces |
| 01/08/2009 | DE102007029612A1 Preparing pentahydroxy-pentylcarbamoyl-undecanoic acid benzyl ester, useful to prepare tetrahydroxy-hexylcarbamoyl-undecanoic acid, comprises reacting dodecanedioic acid monobenzyl ester with halo-carbonyl compound and then with glucamine |
| 01/07/2009 | EP2010485A1 Azetidine derivatives as g-protein coupled receptor (gpr119 ) agonists |
| 01/07/2009 | EP2010227A2 Radiofluorinated compounds and their preparation |
| 01/07/2009 | EP1928821B1 Carboxamide derivatives as muscarinic receptor antagonists |
| 01/07/2009 | EP1667966A4 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
| 01/06/2009 | US7473779 e.g. 2-amino-N-(4-{[amino(2-thienyl)methylidene]amino}phenethyl)-5-methoxybenzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 01/01/2009 | US20090005321 Phenylazetidinone Derivatives |
| 12/31/2008 | WO2009000397A1 Process for preparing benzyl pentahydroxyhexylcarbamoylundecanoate |
| 12/31/2008 | EP2007718A2 Processes for preparing ezetimibe and intermediate compounds useful for the preparation thereof |
| 12/31/2008 | EP1051397B1 Method for preparing an n- (aliphatic or aromatic)carbonyl -2-aminoacetamide compound and a cyclyzed compound |
| 12/31/2008 | CA2691065A1 Process for preparing benzyl pentahydroxyhexylcarbamoylundecanoate |
| 12/30/2008 | US7470678 Diphenylazetidinone derivatives for treating disorders of the lipid metabolism |
| 12/30/2008 | CA2226256C New thrombin inhibitors, their preparation and use |
| 12/30/2008 | CA2186364C Substituted azetidinone compounds useful as hypocholesterolemic agents |
| 12/25/2008 | US20080319206 Process for Preparing Protected Amidines |
| 12/25/2008 | US20080318920 Deuterium-enriched ezetimibe |
| 12/24/2008 | WO2008157565A1 Deuterium-enriched ezetimibe |
| 12/24/2008 | EP1620102B1 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
| 12/24/2008 | CN100444839C Treatment of chemokine mediated diseases |